CareLit · DOI-Nachweis · TumorDiagnostik & Therapie
Combination of mitoxantrone and etoposide in the Treatment of Advanced MyelodysplasticSyndrome/Secondary Acute Myeloid Leukemia - a Multicenter Phase II Study
DOI 10.1055/s-2002-26771
Bibliografische Angaben
Nachweis in CareLit
Autor:innenC. Baldus, L. Balleisen, W. Hirschmann, C. Rudolph, H. Bartels, N. Grobe, T. Zwingers, E. Thiel, W. U. Knauf
ZeitschriftTumorDiagnostik & Therapie
Ausgabe02/2002
Jahrgang / SeitenJg. 23 · S. 57-61
Kernaussage aus der Literatur
Abstract-Vorschau
Abstract BACKGROUND: The combination of mitoxantrone plus etoposide (NOVE) has been shown to be effective in the treatment of relapsed AML and AML in elderly patients. In order to further evaluate this regimen, we conducted a phase II study on NOVE in previously untreated patients diagnosed with sAML/advanced MDS (RAEBt). PATIENTS: A total of 42 evaluable patients with a median age of 61 years (range 37 - 73) were a…
Zitieren
Zitierempfehlung
C. Baldus, L. Balleisen, W. Hirschmann, C. Rudolph, H. Bartels, N. Grobe, T. Zwingers, E. Thiel, W. U. Knauf (2002) Combination of mitoxantrone and etoposide in the Treatment of Advanced MyelodysplasticSyndrome/Secondary Acute Myeloid Leukemia - a Multicenter Phase II Study. TumorDiagnostik & Therapie, 23 (02), 57-61. https://doi.org/10.1055/s-2002-26771
Mit CareLit weiterarbeiten